Pre - registration 
Pay online 
Lab report 
Request for call back
Feedback 
Insurance 
Patients 
International consultants
Dr. Walaa Elsalakawy
Consultant Internal Medicine
Work Experience
- Dr Walaa has nearly 25 years of medical experience in the field of internal medicine.
- She has earned her graduation from the faculty of medicine, Ain Shams University, Cairo, Egypt in 2001.
- She received her master’s degree in Nov 2005 and earned her doctoral degree in internal medicine in Nov 2009.
- She worked as a consultant of internal medicine and hematology in many hospitals inside Egypt including the Ain Shams University hospitals with nearly 15 years of experience after MD.
- She works as a professor of internal medicine and hematology in Ain shams University since 2020.
Languages Spoken
- English
- Arabic
Special Interests
- Diabetes and its complications
- Thyroid diseases
- Hypertension and its complications
- Chest Pain
- Gastrointestinal diseases and malabsorption syndromes
- Abnormal liver function tests and viral infections of the liver (hepatitis virus), fatty liver.
- Anemias (inherited or acquired causes) e.g. hemolysis- sickle cell anemia – G6PD anemia- iron and B12 deficiency anemia
- Bleeding and skin bruising
- Thrombosis, DVT and recurrent abortions (medical causes)
- Immunity disorders , recurrent infections
- Abnormalities in blood cells (red blood cells, white blood cells or platelets)
- Abnormalities of blood proteins.
- Diabetic nephropathy- chronic kidney disease
- Systemic lupus erythromatosis- rheumatoid arthritis- joint inflammation and pain
Research and Publications
As a university staff and a professor, dr Walaa has designed and supervised many articles that was published in international and national journals
EHA (European Hematology Association) publications
- Serum follistatin level as a prognostic marker in Haploidentical stem cell transplantation
- Value of vanin-1 assessment in adult patients with primary immune thrombocytopenia
- ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients with chronic-phase chronic myeloid leukemia receiving imatinib mesylate
- First report of expansion of CD4+/CD28 null T-helper lymphocytes in adult patients with idiopathic autoimmune hemolytic anemia
- First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients
- Serum erythroferrone diagnostic value in patients with beta-thalassemia with iron overload
- Assessment of B-lymphocyte and T-lymphocyte function in patients with myelodysplastic syndromes
- Leukemia stem cell markers (CD 123 and CD25) are poor prognostic markers in patients with adult acute myeloid leukemia
- Predictive value of the proliferation marker Ki-67 in patients with acute leukemia undergoing hematopoietic stem cell transplantation
- Flow cytometric evaluation of CD200 as a tool for differentiation between chronic lymphocytic leukemia and mantle cell lymphoma
- Blood indices to differentiate between β-thalassemia trait and iron deficiency anemia in adult healthy Egyptian blood donors
- High levels of soluble thrombomodulin may be a marker of arterial disease and peripheral ischemia in Egyptian patients with diabetes mellitus
- Cost-effectiveness of postremission intensive chemotherapy in comparison with allogeneic stem-cell transplantation in adult Egyptian patients with acute myeloid leukemia
- Prognostic significance of intracellular survivin in myeloid blast cells as an inhibitor of apoptosis in Egyptian adult acute myeloid leukemia patients
